I do not believe LL will only be used as last resort only. I believe it should be used in all stages of treatment. Majority of cancer die because of metastasis, not the [primary tumor. Once used this way, I believe 5-year survival rates will cross past the 50% mark. We might not become Big Pharma (YET), but we will become a well-respected pharmaceutical company. Nasdaq listed and a positive balance sheet with positive cash flow.